Granulocyte-colony stimulating factor promotes proliferation, migration and invasion in glioma cells

References

• Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114:97 - 109; http://dx.doi.org/10.1007/s00401-007-0243-4; PMID: 17618441
   PubMed Web of Science ®Google Scholar
• Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al, European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups, National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352:987 - 96; http://dx.doi.org/10.1056/NEJMoa043330; PMID: 15758009
   PubMed Web of Science ®Google Scholar
• Kleihues P, Soylemezoglu F, Schäuble B, Scheithauer BW, Burger PC. Histopathology, classification, and grading of gliomas. Glia 1995; 15:211 - 21; http://dx.doi.org/10.1002/glia.440150303; PMID: 8586458
   PubMed Web of Science ®Google Scholar
• Morstyn G, Burgess AW. Hemopoietic growth factors: a review. Cancer Res 1988; 48:5624 - 37; PMID: 2458827
   PubMed Web of Science ®Google Scholar
• Solaroglu I, Cahill J, Jadhav V, Zhang JH. A novel neuroprotectant granulocyte-colony stimulating factor. Stroke 2006; 37:1123 - 8; http://dx.doi.org/10.1161/01.STR.0000208205.26253.96; PMID: 16514095
   PubMed Web of Science ®Google Scholar
• Lee ST, Park JE, Kim DH, Kim S, Im WS, Kang L, et al. Granulocyte-colony stimulating factor attenuates striatal degeneration with activating survival pathways in 3-nitropropionic acid model of Huntington’s disease. Brain Res 2008; 1194:130 - 7; http://dx.doi.org/10.1016/j.brainres.2007.11.058; PMID: 18166168
   PubMed Web of Science ®Google Scholar
• Mattei S, Colombo MP, Melani C, Silvani A, Parmiani G, Herlyn M. Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int J Cancer 1994; 56:853 - 7; http://dx.doi.org/10.1002/ijc.2910560617; PMID: 7509778
   PubMed Web of Science ®Google Scholar
• Nakata H, Uemura Y, Kobayashi M, Harada R, Taguchi H. Cyclooxygenase-2 inhibitor NS-398 suppresses cell growth and constitutive production of granulocyte-colony stimulating factor and granulocyte macrophage-colony stimulating factor in lung cancer cells. Cancer Sci 2003; 94:173 - 80; http://dx.doi.org/10.1111/j.1349-7006.2003.tb01415.x; PMID: 12708493
   PubMed Web of Science ®Google Scholar
• Chakraborty A, White SM, Lerner SP. Granulocyte colony-stimulating factor receptor signals for beta1-integrin expression and adhesion in bladder cancer. Urology 2004; 63:177 - 83; http://dx.doi.org/10.1016/S0090-4295(03)00786-6; PMID: 14751388
   PubMed Web of Science ®Google Scholar
• Pirtskhalaishvili G, Nelson JB. Endothelium-derived factors as paracrine mediators of prostate cancer progression. Prostate 2000; 44:77 - 87; http://dx.doi.org/10.1002/1097-0045(20000615)44:1<77::AID-PROS10>3.0.CO;2-G; PMID: 10861760
   PubMed Web of Science ®Google Scholar
• Nitta T, Sato K, Allegretta M, Brocke S, Lim M, Mitchell DJ, et al. Expression of granulocyte colony stimulating factor and granulocyte-macrophage colony stimulating factor genes in human astrocytoma cell lines and in glioma specimens. Brain Res 1992; 571:19 - 25; http://dx.doi.org/10.1016/0006-8993(92)90505-4; PMID: 1377084
   PubMed Web of Science ®Google Scholar
• Mueller MM, Herold-Mende CC, Riede D, Lange M, Steiner HH, Fusenig NE. Autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor in human gliomas with tumor progression. Am J Pathol 1999; 155:1557 - 67; http://dx.doi.org/10.1016/S0002-9440(10)65472-7; PMID: 10550313
   PubMed Web of Science ®Google Scholar
• Mueller MM, Peter W, Mappes M, Huelsen A, Steinbauer H, Boukamp P, et al. Tumor progression of skin carcinoma cells in vivo promoted by clonal selection, mutagenesis, and autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. Am J Pathol 2001; 159:1567 - 79; http://dx.doi.org/10.1016/S0002-9440(10)62541-2; PMID: 11583982
   PubMed Web of Science ®Google Scholar
• Mueller MM, Fusenig NE. Constitutive expression of G-CSF and GM-CSF in human skin carcinoma cells with functional consequence for tumor progression. Int J Cancer 1999; 83:780 - 9; http://dx.doi.org/10.1002/(SICI)1097-0215(19991210)83:6<780::AID-IJC14>3.0.CO;2-C; PMID: 10597195
   PubMed Web of Science ®Google Scholar
• Eaves C, Jiang X, Eisterer W, Chalandon Y, Porada G, Zanjani E, et al. New models to investigate mechanisms of disease genesis from primitive BCR-ABL(+) hematopoietic cells. Ann N Y Acad Sci 2003; 996:1 - 9; http://dx.doi.org/10.1111/j.1749-6632.2003.tb03226.x; PMID: 12799276
   PubMed Web of Science ®Google Scholar
• Jung KH, Chu K, Lee ST, Kim SJ, Sinn DI, Kim SU, et al. Granulocyte colony-stimulating factor stimulates neurogenesis via vascular endothelial growth factor with STAT activation. Brain Res 2006; 1073-1074:190 - 201; http://dx.doi.org/10.1016/j.brainres.2005.12.037; PMID: 16423324
   PubMed Web of Science ®Google Scholar
• Liu H, Jia D, Fu J, Zhao S, He G, Ling EA, et al. Effects of granulocyte colony-stimulating factor on the proliferation and cell-fate specification of neural stem cells. Neuroscience 2009; 164:1521 - 30; http://dx.doi.org/10.1016/j.neuroscience.2009.09.045; PMID: 19782730
   PubMed Web of Science ®Google Scholar
• Zheng H, Ying H, Yan H, Kimmelman AC, Hiller DJ, Chen AJ, et al. Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma. Cold Spring Harb Symp Quant Biol 2008; 73:427 - 37; http://dx.doi.org/10.1101/sqb.2008.73.047; PMID: 19150964
   PubMedGoogle Scholar
• Wang Y, Yang J, Zheng H, Tomasek GJ, Zhang P, McKeever PE, et al. Expression of mutant p53 proteins implicates a lineage relationship between neural stem cells and malignant astrocytic glioma in a murine model. Cancer Cell 2009; 15:514 - 26; http://dx.doi.org/10.1016/j.ccr.2009.04.001; PMID: 19477430
   PubMed Web of Science ®Google Scholar
• Nicola NA. Hemopoietic cell growth factors and their receptors. Annu Rev Biochem 1989; 58:45 - 77; http://dx.doi.org/10.1146/annurev.bi.58.070189.000401; PMID: 2549855
   PubMed Web of Science ®Google Scholar
• Ward AC, Hermans MH, Smith L, van Aesch YM, Schelen AM, Antonissen C, et al. Tyrosine-dependent and -independent mechanisms of STAT3 activation by the human granulocyte colony-stimulating factor (G-CSF) receptor are differentially utilized depending on G-CSF concentration. Blood 1999; 93:113 - 24; PMID: 9864153
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008; 455:1061 - 8; http://dx.doi.org/10.1038/nature07385; PMID: 18772890
   PubMed Web of Science ®Google Scholar
• de Koning JP, Dong F, Smith L, Schelen AM, Barge RM, van der Plas DC, et al. The membrane-distal cytoplasmic region of human granulocyte colony-stimulating factor receptor is required for STAT3 but not STAT1 homodimer formation. Blood 1996; 87:1335 - 42; PMID: 8608222
   PubMed Web of Science ®Google Scholar
• Rusthoven J, Bramwell V, Stephenson B, Provincial Systemic Treatment Disease Site Group. Use of granulocyte colony-stimulating factor (G-CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer. Cancer Prev Control 1998; 2:179 - 90; PMID: 10093631
   PubMedGoogle Scholar
• Sabeh F, Shimizu-Hirota R, Weiss SJ. Protease-dependent versus -independent cancer cell invasion programs: three-dimensional amoeboid movement revisited. J Cell Biol 2009; 185:11 - 9; http://dx.doi.org/10.1083/jcb.200807195; PMID: 19332889
   PubMed Web of Science ®Google Scholar
• Malipiero UV, Frei K, Fontana A. Production of hemopoietic colony-stimulating factors by astrocytes. J Immunol 1990; 144:3816 - 21; PMID: 1692062
   PubMed Web of Science ®Google Scholar
• Huang H, Held-Feindt J, Buhl R, Mehdorn HM, Mentlein R. Expression of VEGF and its receptors in different brain tumors. Neurol Res 2005; 27:371 - 7; http://dx.doi.org/10.1179/016164105X39833; PMID: 15949234
   PubMed Web of Science ®Google Scholar
• Joensuu H, Puputti M, Sihto H, Tynninen O, Nupponen NN. Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme. J Pathol 2005; 207:224 - 31; http://dx.doi.org/10.1002/path.1823; PMID: 16021678
   PubMed Web of Science ®Google Scholar
• Ohki Y, Heissig B, Sato Y, Akiyama H, Zhu Z, Hicklin DJ, et al. Granulocyte colony-stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils. FASEB J 2005; 19:2005 - 7; http://dx.doi.org/10.1096/fj.04-3496fje; PMID: 16223785
   PubMed Web of Science ®Google Scholar
• Haura EB, Turkson J, Jove R. Mechanisms of disease: Insights into the emerging role of signal transducers and activators of transcription in cancer. Nat Clin Pract Oncol 2005; 2:315 - 24; http://dx.doi.org/10.1038/ncponc0195; PMID: 16264989
   PubMedGoogle Scholar
• Brantley EC, Benveniste EN. Signal transducer and activator of transcription-3: a molecular hub for signaling pathways in gliomas. Mol Cancer Res 2008; 6:675 - 84; http://dx.doi.org/10.1158/1541-7786.MCR-07-2180; PMID: 18505913
   PubMed Web of Science ®Google Scholar
• Yin C, Knudson CM, Korsmeyer SJ, Van Dyke T. Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 1997; 385:637 - 40; http://dx.doi.org/10.1038/385637a0; PMID: 9024662
   PubMed Web of Science ®Google Scholar
• Yin XM, Oltvai ZN, Korsmeyer SJ. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 1994; 369:321 - 3; http://dx.doi.org/10.1038/369321a0; PMID: 8183370
   PubMed Web of Science ®Google Scholar
• McKernan DP, Dinan TG, Cryan JF. “Killing the Blues”: a role for cellular suicide (apoptosis) in depression and the antidepressant response?. Prog Neurobiol 2009; 88:246 - 63; http://dx.doi.org/10.1016/j.pneurobio.2009.04.006; PMID: 19427352
   PubMed Web of Science ®Google Scholar
• Niola F, Evangelisti C, Campagnolo L, Massalini S, Buè MC, Mangiola A, et al. A plasmid-encoded VEGF siRNA reduces glioblastoma angiogenesis and its combination with interleukin-4 blocks tumor growth in a xenograft mouse model. Cancer Biol Ther 2006; 5:174 - 9; http://dx.doi.org/10.4161/cbt.5.2.2317; PMID: 16340308
   PubMed Web of Science ®Google Scholar
• Brantley EC, Benveniste EN. Signal transducer and activator of transcription-3: a molecular hub for signaling pathways in gliomas. Mol Cancer Res 2008; 6:675 - 84; http://dx.doi.org/10.1158/1541-7786.MCR-07-2180; PMID: 18505913
   PubMed Web of Science ®Google Scholar
• Weissenberger J, Loeffler S, Kappeler A, Kopf M, Lukes A, Afanasieva TA, et al. IL-6 is required for glioma development in a mouse model. Oncogene 2004; 23:3308 - 16; http://dx.doi.org/10.1038/sj.onc.1207455; PMID: 15064729
   PubMed Web of Science ®Google Scholar
• Sabeh F, Shimizu-Hirota R, Weiss SJ. Protease-dependent versus -independent cancer cell invasion programs: three-dimensional amoeboid movement revisited. J Cell Biol 2009; 185:11 - 9; http://dx.doi.org/10.1083/jcb.200807195; PMID: 19332889
   PubMed Web of Science ®Google Scholar
• Komatsu K, Nakanishi Y, Nemoto N, Hori T, Sawada T, Kobayashi M. Expression and quantitative analysis of matrix metalloproteinase-2 and -9 in human gliomas. Brain Tumor Pathol 2004; 21:105 - 12; http://dx.doi.org/10.1007/BF02482184; PMID: 15696970
   PubMedGoogle Scholar
• Zhang Q, Chen X, Zhou J, Zhang L, Zhao Q, Chen G, et al. CD147, MMP-2, MMP-9 and MVD-CD34 are significant predictors of recurrence after liver transplantation in hepatocellular carcinoma patients. Cancer Biol Ther 2006; 5:808 - 14; doi.org/10.4161/cbt.5.7.2754 http://dx.doi.org/10.4161/cbt.5.7.2754; PMID: 16775432
   PubMed Web of Science ®Google Scholar
• Yamamoto N, Sekine I, Nakagawa K, Takada M, Fukuoka M, Tanigawara Y, et al. A pharmacokinetic and dose escalation study of pegfilgrastim (KRN125) in lung cancer patients with chemotherapy-induced neutropenia. Jpn J Clin Oncol 2009; 39:425 - 30; http://dx.doi.org/10.1093/jjco/hyp038; PMID: 19395467
   PubMed Web of Science ®Google Scholar
• Zhang Y, Hao H, Zhao S, Liu Q, Yuan Q, Ni S, et al. Downregulation of GRIM-19 promotes growth and migration of human glioma cells. Cancer Sci 2011; 102:1991 - 9; http://dx.doi.org/10.1111/j.1349-7006.2011.02059.x; PMID: 21827581
   PubMed Web of Science ®Google Scholar